1200x200 october 13 DDN

Register for the Webinar

Already registered?
Access the webinar here »

Engineered chimeric antigen receptor (CAR) immune cells successfully treat lymphomas; however, they are less efficient in targeting and eliminating solid tumors. Trafficking and ensuring their survival in the tumor microenvironment until all cancer cells are eliminated remains a challenge. In this webinar, experts will discuss advances that bring CAR therapy for solid tumors one step closer to reality.

Topics to be covered

  • Engineering off-the-shelf CAR immune cells
  • Improving CAR T therapy efficacy with the gut microbiome

Speaker Information:

Tamara-Laskowski circle

Tamara Laskowski, PhD

Scientific Project Director

CAR NK Program, Adoptive Cell Therapy Platform

Department of Stem Cell Transplantation and Cellular Therapy

MD Anderson Cancer Center

Maik-Luu.jpeg circle

Maik Luu, PhD

Project Principal Investigator

University Hospital Würzburg

Scientific Project Manager



Webinar Sponsor